PK Bio is working towards developing innovative oral medicines targeting to improve the health of patients with neurodegenerative diseases.
IDED awards PK Biosciences corporation and BodyViz under the Information Technology Joint Venture Program to develop 4D Virtual Dissection Software.
We have a series of compounds with neuroprotective and anti-neuroinflammatory indications in animal models and in preclinical stage.
We have a portfolio of proprietary compounds selectively targeting cell death signaling molecules implicated in neuroinflammation and neurodegeneration.
CALL US AT (515) 735-2185
Our neuroprotective technology was reviewed and ranked among top neuroprotective approaches by Foresight Science &Technology™ Company, initiated by NIH.
Copyright © PK Biosciences Corporation. All rights reserved
CALL US at (515) 735-2185